Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AKLI Akili	$0.43	$0.43	$0.19 ▼ $1.25	$34.01M	1.72	2.20 million shs	N/A
HYPR Hyperfine	$1.28 +0.8%	$0.94	$0.53 ▼ $1.90	$99.63M	1.06	1.43 million shs	146,120 shs
MBOT Microbot Medical	$3.31 +7.1%	$2.65	$0.82 ▼ $3.38	$150.77M	1.15	3.05 million shs	4.12 million shs
PDEX Pro-Dex	$44.74 +1.9%	$45.14	$19.80 ▼ $70.26	$145.85M	0.19	46,992 shs	13,852 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AKLI Akili	0.00%	0.00%	0.00%	0.00%	0.00%
HYPR Hyperfine	-1.55%	+5.83%	+38.03%	+115.25%	+18.14%
MBOT Microbot Medical	+0.32%	-0.96%	+25.10%	+21.65%	+200.00%
PDEX Pro-Dex	-0.41%	+11.42%	-4.91%	-1.08%	+125.12%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AKLI Akili	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HYPR Hyperfine	1.5216 of 5 stars	1.3	5.0	0.0	0.0	2.5	1.7	0.6
MBOT Microbot Medical	1.5242 of 5 stars	3.5	1.0	0.0	0.0	1.7	0.0	0.6
PDEX Pro-Dex	2.683 of 5 stars	3.5	1.0	0.0	0.0	1.6	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AKLI Akili	0.00	N/A	N/A	N/A
HYPR Hyperfine	2.67	Moderate Buy	$1.28	0.26% Upside
MBOT Microbot Medical	3.00	Buy	$9.00	171.90% Upside
PDEX Pro-Dex	3.00	Buy	$56.00	25.17% Upside

Current Analyst Ratings Breakdown

Latest AKLI, PDEX, MBOT, and HYPR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	HYPR Hyperfine	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$0.68 ➝ $0.85
8/14/2025	HYPR Hyperfine	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1.50 ➝ $2.00
6/3/2025	HYPR Hyperfine	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/27/2025	PDEX Pro-Dex	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$54.00 ➝ $56.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AKLI Akili	$1.95M	17.46	N/A	N/A	$0.75 per share	0.58
HYPR Hyperfine	$10.80M	9.23	N/A	N/A	$0.45 per share	2.84
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A
PDEX Pro-Dex	$53.84M	2.71	$0.97 per share	46.05	$9.03 per share	4.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AKLI Akili	-$59.49M	-$0.61	N/A	N/A	N/A	-2,492.04%	-79.93%	-59.16%	N/A
HYPR Hyperfine	-$40.72M	-$0.52	N/A	N/A	N/A	-364.54%	-84.82%	-69.39%	N/A
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	N/A
PDEX Pro-Dex	$2.13M	$2.80	15.98	21.72	N/A	14.61%	29.08%	16.19%	9/4/2025 (Estimated)

Latest AKLI, PDEX, MBOT, and HYPR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2025	Q4 2025	PDEX Pro-Dex	$0.47	N/A	N/A	N/A	$17.90 million	N/A
8/13/2025	Q2 2025	HYPR Hyperfine	-$0.12	-$0.12	N/A	-$0.12	$3.00 million	$2.70 million
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A
5/21/2025	Q1 2025	MBOT Microbot Medical	-$0.15	-$0.08	+$0.07	-$0.08	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AKLI Akili	N/A	N/A	N/A	N/A	N/A
HYPR Hyperfine	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AKLI Akili	0.08	5.80	5.80
HYPR Hyperfine	N/A	5.02	4.41
MBOT Microbot Medical	N/A	12.06	12.06
PDEX Pro-Dex	0.28	2.73	1.45

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AKLI Akili	53.12%
HYPR Hyperfine	15.03%
MBOT Microbot Medical	16.30%
PDEX Pro-Dex	15.28%

Insider Ownership

Company	Insider Ownership
AKLI Akili	10.10%
HYPR Hyperfine	30.98%
MBOT Microbot Medical	4.74%
PDEX Pro-Dex	47.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AKLI Akili	130	78.73 million	70.78 million	Optionable
HYPR Hyperfine	190	77.83 million	53.72 million	Optionable
MBOT Microbot Medical	20	45.55 million	43.39 million	Optionable
PDEX Pro-Dex	140	3.26 million	1.71 million	Not Optionable

AKLI, PDEX, MBOT, and HYPR Headlines

Recent News About These Companies

Pro-Dex (NASDAQ:PDEX) Downgraded to "Hold" Rating by Wall Street Zen

August 19 at 2:27 AM | americanbankingnews.com

Hedge funds investors have a lot riding on Pro-Dex, Inc. (NASDAQ:PDEX) with 37% ownership

August 18 at 9:20 PM | uk.finance.yahoo.com

Pro-Dex (NASDAQ:PDEX) Cut to Hold at Wall Street Zen

August 17 at 2:15 AM | marketbeat.com

Pro-Dex (NASDAQ:PDEX) Stock Passes Above 200 Day Moving Average - Here's Why

August 6, 2025 | marketbeat.com

Strength Seen in ProDex (PDEX): Can Its 8.2% Jump Turn into More Strength?

July 29, 2025 | zacks.com

Navellier & Associates Inc. Purchases New Shares in Pro-Dex, Inc. (NASDAQ:PDEX)

July 27, 2025 | marketbeat.com

Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200 Day Moving Average - Time to Sell?

July 26, 2025 | marketbeat.com

Pro-Dex, Inc. (PDEX) - Yahoo Finance

July 16, 2025 | finance.yahoo.com

New Strong Buy Stocks for July 1st

July 1, 2025 | zacks.com

Best Value Stocks to Buy for July 1st

July 1, 2025 | zacks.com

Pro-Dex, Inc. (PDEX) Stock Price, Quote, News & Analysis - Seeking Alpha

June 27, 2025 | seekingalpha.com

Investors Shouldn't Overlook The Favourable Returns On Capital At Pro-Dex (NASDAQ:PDEX)

June 23, 2025 | finance.yahoo.com

Here is Why Growth Investors Should Buy ProDex (PDEX) Now

June 17, 2025 | zacks.com

ProDex (PDEX) Upgraded to Buy: Here's Why

June 17, 2025 | zacks.com

Are Pro-Dex, Inc.'s (NASDAQ:PDEX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

May 20, 2025 | finance.yahoo.com

Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity

May 5, 2025 | seekingalpha.com

Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors

May 4, 2025 | uk.finance.yahoo.com

Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates

May 1, 2025 | zacks.com

Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results

May 1, 2025 | accessnewswire.comA

ProDex (PDEX) Moves 5.1% Higher: Will This Strength Last?

April 25, 2025 | zacks.com

Take the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in Focus

April 21, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AKLI, PDEX, MBOT, and HYPR Company Descriptions

Akili NASDAQ:AKLI

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.

Hyperfine NASDAQ:HYPR

$1.28 +0.01 (+0.79%)

Closing price 04:00 PM Eastern

Extended Trading

$1.27 -0.01 (-0.78%)

As of 05:21 PM Eastern

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Microbot Medical NASDAQ:MBOT

$3.31 +0.22 (+7.12%)

Closing price 04:00 PM Eastern

Extended Trading

$3.32 +0.01 (+0.30%)

As of 05:49 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Pro-Dex NASDAQ:PDEX

$44.74 +0.82 (+1.87%)

Closing price 04:00 PM Eastern

Extended Trading

$44.78 +0.03 (+0.08%)

As of 04:27 PM Eastern

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time